🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hereditary Ataxia

Biomarker Research in Inherited Movement Disorders NCT05034172n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Clinical follow-up Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) NCT06593951n/a1 site📍 Boston Boston Children's Hospital Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) NCT07215416Phase 1, Phase 21 site📍 Boston Timothy Yu · Tests: Antisense oligonucleotide targeting the ATM gene Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… Rare Disease Registry Database for Movement Disorders in Southern Anhui Province NCT07838883n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia NCT07013292n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: SKYCLARYS (omaveloxolone) An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias NCT07798674n/a30 sites📍 Innsbruck📍 Prague📍 Paris Heidelberg University Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia NCT05302271Phase 11 site📍 New York Weill Medical College of Cornell University · Tests: AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN… A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD NCT05822908Phase 1, Phase 214 sites📍 Copenhagen📍 Angers📍 Montpellier Vico Therapeutics B. V. · Tests: VO659 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases NCT00874783n/a1 site📍 Jerusalem Hadassah Medical Organization Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL) NCT03624374n/a1 site📍 Baltimore Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity NCT06600269NA1 site📍 Taoyuan Chang Gung University · Tests: Cycling Training Biomarkers in Friedreich's Ataxia NCT02497534n/a1 site📍 Gainesville University of Florida Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Hong Kong Spinocerebellar Ataxias Registry NCT03336008n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: no intervention Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases. NCT04880356n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Tests: collection of data Interposed Nucleus aDBS for Ataxia NCT07325487NA1 site📍 Gainesville University of Florida · Tests: Deep Brain Stimulation Home Exercise for Individuals With Neurodegenerative Disease NCT05443906NA1 site📍 Baltimore Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Tests: Home exercise Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta NCT07092358n/a2 sites📍 Hangzhou📍 Shanghai Second Affiliated Hospital, Zhejiang University, School of … · Tests: None of intervention North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) NCT01694940n/a17 sites📍 San Diego📍 Stanford📍 Aurora Columbia University Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias NCT07019558NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Neurological assessment, Ophthalmological assessment Pivotal Study of N-acetyl-L-leucine for CACNA1A NCT07221292Phase 311 sites📍 Baltimore📍 Boston📍 Houston IntraBio Inc · Tests: N-Acetyl-L-Leucine, Placebo The Cancer of the Pancreas Screening-5 CAPS5)Study NCT02000089Phase 39 sites📍 New Haven📍 Baltimore📍 Boston Johns Hopkins University · Tests: Secretin, MRI, Tumor marker gene test with CA19-9 Autosomal Dominant Spinocerebellar Ataxias and Social Cognition NCT07099651NA1 site📍 Angers University Hospital, Angers · Tests: tests A Study of SGT-212 Gene Therapy in Friedreich's Ataxia NCT07180355Phase 13 sites📍 Los Angeles📍 Columbus📍 Philadelphia Solid Biosciences Inc. · Tests: SGT-212 Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study NCT02841553n/a1 site📍 St Louis Washington University School of Medicine A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies NCT06628687n/a1 site📍 Morrisville Biogen · Tests: Omaveloxolone A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors NCT06623890n/a14 sites📍 Los Angeles📍 Aurora📍 Gainesville Biogen · Tests: Omaveloxolone
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy